Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolution

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Fink, Darci M ^a   Connor, Alicia L ^b   Kelley, Philip M ^b   Steele, Maria M ^a   Hollingsworth, Michael A ^a   Tempero, Richard M ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGF PROTEIN, HUMAN; NGFR PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORNEAL MICROPOCKET ASSAY; DERMAL LYMPHATIC ENDOTHELIAL CELL; DISEASE COURSE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; EYE PAIN; EYE SWELLING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; KERATITIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; MOUSE MODEL; NEUROLYMPHATIC VESSEL REMODELING; NOCICEPTION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WOUND HEALING; ADULT; ANIMAL; CELL CULTURE; CORNEA; DISEASE MODEL; DRUG EFFECTS; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY;

ADULT; ANIMALS; CELLS, CULTURED; CORNEA; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MICE; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; WOUND HEALING;

EID: 84911376145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112737     Document Type: Article

References (62)

1. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, et al. (2007) Resolution of inflammation: State of the art, definitions and terms. FASEB J 21:325-332.
2. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: Dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361.
3. Serhan CN, Savill J (2005) Resolution of inflammation: The beginning programs the end. Nat Immunol 6: 1191-1197.
4. Melani M, Weinstein BM (2010) Common factors regulating patterning of the nervous and vascular systems. Annu Rev Cell Dev Biol 26: 639-665.
5. Adams RH, Eichmann A (2010) Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol 2: a001875.
6. Gelfand MV, Hong S, Gu C (2009) Guidance from above: Common cues direct distinct signaling outcomes in vascular and neural patterning. Trends Cell Biol 19: 99-110.
7. Larrivee B, Freitas C, Suchting S, Brunet I, Eichmann A (2009) Guidance of vascular development: Lessons from the nervous system. Circ Res 104: 428-441.
8. Bouvree K, Brunet I, Del Toro R, Gordon E, Prahst C, et al. (2012) Semaphorin3A, neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ Res 111: 437-445.
9. Chauvet S, Burk K, Mann F (2013) Navigation rules for vessels and neurons: Cooperative signaling between VEGF and neural guidance cues. Cell Mol Life Sci 70: 1685-1703.
10. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ (2002) Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 109: 693-705.
11. Quaegebeur A, Lange C, Carmeliet P (2011) The neurovascular link in health and disease: Molecular mechanisms and therapeutic implications. Neuron 71:406-424.
12. Buchler P, Gazdhar A, Schubert M, Giese N, Reber HA, et al. (2005) The notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg 242: 791-800, discussion 800-1.
13. Entschladen F, Palm D, Niggemann B, Zaenker KS (2008) The cancer's nervous tooth: Considering the neuronal crosstalk within tumors. Semin Cancer Biol 18:171-175.
14. Entschladen F, Palm D, Lang K, Drell TL, 4th, Zaenker KS (2006) Neoneurogenesis: Tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med Hypotheses 67: 33-35.
15. Zander E, Weddell G (1951) Observations on the innervation of the cornea. J Anat 85: 68-99.
16. McKenna CC, Lwigale PY (2011) Innervation of the mouse cornea during development. Invest Ophthalmol Vis Sci 52: 30-35.
17. Muller LJ, Marfurt CF, Kruse F, Tervo TM (2003) Corneal nerves: Structure, contents and function. Exp Eye Res 76: 521-542.
18. Belmonte C, Acosta MC, Gallar J (2004) Neural basis of sensation in intact and injured corneas. Exp Eye Res 78: 513-525.
19. Marfurt CF, Kingsley RE, Echtenkamp SE (1989) Sensory and sympathetic innervation of the mammalian cornea. A retrograde tracing study. Invest Ophthalmol Vis Sci 30: 461-472.
20. Marfurt CF, Jones MA, Thrasher K (1998) Parasympathetic innervation of the rat cornea. Exp Eye Res 66: 437-448.
21. Kelley PM, Steele MM, Tempero RM (2011) Regressed lymphatic vessels develop during corneal repair. Lab Invest 91: 1643-1651.
22. Kelley PM, Connor AL, Tempero RM (2013) Lymphatic vessel memorystimulated by recurrent inflammation. Am J Pathol 182: 2418-2428.
23. Kankaanpaa P, Paavolainen L, Tiitta S, Karjalainen M, Paivarinne J, et al.(2012) BioImageXD: An open, general-purpose and high-throughput imageprocessing platform. Nat Methods 9: 683-689.
24. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
25. Donaghy M (2003) Enlarged peripheral nerves. Practical Neurology 3: 40-45.
26. Ferrari G, Hajrasouliha AR, Sadrai Z, Ueno H, Chauhan SK, et al. (2013) Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci 54: 813-820.
27. Woo HM, Bentley E, Campbell SF, Marfurt CF, Murphy CJ (2005) Nerve growth factor and corneal wound healing in dogs. Exp Eye Res 80: 633-642.
28. Lambiase A, Manni L, Bonini S, Rama P, Micera A, et al. (2000) Nerve growth factor promotes corneal healing: Structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 41: 1063-1069.
29. Sornelli F, Lambiase A, Mantelli F, Aloe L (2010) NGF and NGF-receptor expression of cultured immortalized human corneal endothelial cells. Mol Vis 16: 1439-1447.
30. Blanco-Mezquita T, Martinez-Garcia C, Proenca R, Zieske JD, Bonini S, et al. (2013) Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9. Invest Ophthalmol Vis Sci 54: 3880-3890.
31. Lambiase A, Bonini S, Micera A, Rama P, Bonini S, et al. (1998) Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 39:1272-1275.
32. You L, Kruse FE, Volcker HE (2000) Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci 41: 692-702.
33. Esquenazi S, Bazan HE, Bui V, He J, Kim DB, et al. (2005) Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest Ophthalmol Vis Sci 46: 3121-3127.
34. Lambiase A, Aloe L, Mantelli F, Sacchetti M, Perrella E, et al. (2012) Capsaicininduced corneal sensory denervation and healing impairment are reversed by NGF treatment. Invest Ophthalmol Vis Sci 53: 8280-8287.
35. Sweat RS, Sloas DC, Murfee WL (2014) VEGF-C induces lymphangiogenesis and angiogenesis in the rat mesentery culture model. Microcirculation.
36. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, et al. (1997) VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96-109.
37. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
38. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, et al. (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94: 664-670.
39. Seo K, Choi J, Park M, Rhee C (2001) Angiogenesis effects of nerve growth factor (NGF) on rat corneas. J Vet Sci 2: 125-130.
40. Mukouyama YS, Gerber HP, Ferrara N, Gu C, Anderson DJ (2005) Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132: 941-952.
41. Saygili E, Pekassa M, Saygili E, Rackauskas G, Hommes D, et al. (2011) Mechanical stretch of sympathetic neurons induces VEGF expression via a NGF and CNTF signaling pathway. Biochem Biophys Res Commun 410: 62-67.
42. Calza L, Giardino L, Giuliani A, Aloe L, Levi-Montalcini R (2001) Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci U S A 98: 4160-4165.
43. Nakamura K, Tan F, Li Z, Thiele CJ (2011) NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxia-inducible factor-1alpha. Mol Cell Neurosci 46: 498-506.
44. Samii A, Unger J, Lange W (1999) Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Neurosci Lett 262: 159-162.
45. Li W, Kohara H, Uchida Y, James JM, Soneji K, et al. (2013) Peripheral nervederived CXCL12 and VEGF-A regulate the patterning of arterial vessel branching in developing limb skin. Dev Cell 24: 359-371.
46. Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, et al. (2007) Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 48: 2545-2552.
47. Bock F, Onderka J, Rummelt C, Dietrich T, Bachmann B, et al. (2009) Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci 50: 2095-2102.
48. Rossi S, Mantelli F, Lambiase A, Aloe L (2012) Bevacizumab eye drop treatment stimulates tear secretion in rats through changes in VEGF and NGF lacrimal gland levels. Arch Ital Biol 150: 15-21.
49. Kim EC, Lee WS, Kim MS (2010) The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats. Invest Ophthalmol Vis Sci 51: 4569-4573.
50. Jee D, Lee WK (2012) Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor. Curr Eye Res 37: 408-415.
51. Li Z, Burns AR, Han L, Rumbaut RE, Smith CW (2011) IL-17 and VEGF are necessary for efficient corneal nerve regeneration. Am J Pathol 178: 1106-1116.
52. Yu CQ, Zhang M, Matis KI, Kim C, Rosenblatt MI (2008) Vascular endothelial growth factor mediates corneal nerve repair. Invest Ophthalmol Vis Sci 49:3870-3878.
53. de Castro F, Silos-Santiago I, Lopez de Armentia M, Barbacid M, Belmonte C (1998) Corneal innervation and sensitivity to noxious stimuli in trkA knockout mice. Eur J Neurosci 10: 146-152.
54. Joo MJ, Yuhan KR, Hyon JY, Lai H, Hose S, et al. (2004) The effect of nerve growth factor on corneal sensitivity after laser in situ keratomileusis. Arch Ophthalmol 122: 1338-1341.
55. Lambiase A, Bonini S, Aloe L, Rama P, Bonini S (2000) Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 118: 1446-1449.
56. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 338:1174-1180.
57. Lambiase A, Manni L, Rama P, Bonini S (2003) Clinical application of nerve growth factor on human corneal ulcer. Arch Ital Biol 141: 141-148.
58. Tan MH, Bryars J, Moore J (2006) Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea 25: 352-355.
59. Cellini M, Bendo E, Bravetti GO, Campos EC (2006) The use of nerve growth factor in surgical wound healing of the cornea. Ophthalmic Res 38: 177-181.
60. Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107: 1347-51; discussion 1351-2.
61. Lambiase A, Mantelli F, Sacchetti M, Rossi S, Aloe L, et al. (2011) Clinical applications of NGF in ocular diseases. Arch Ital Biol 149: 283-292.
62. Mauro C, Pietro L, Emilio CC (2007) The use of nerve growth factor in herpetic keratitis: A case report. J Med Case Rep 1: 124.